Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H34O6 |
Molecular Weight | 370.4804 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(=O)CCCCC(O)=O
InChI
InChIKey=KFGOFTHODYBSGM-ZUNNJUQCSA-N
InChI=1S/C20H34O6/c1-2-3-4-7-14(21)10-11-16-17(19(24)13-18(16)23)12-15(22)8-5-6-9-20(25)26/h10-11,14,16-19,21,23-24H,2-9,12-13H2,1H3,(H,25,26)/b11-10+/t14-,16+,17+,18+,19-/m0/s1
6-Ketoprostaglandin F1alpha (6-keto PGF1a) is a stable hydrolysis product of prostacyclin (PGI2). Due to the short half-life of PGI2, the production of prostacyclin is typically monitored by measurement of the 6-keto-PGF1a metabolite. 6-keto prostaglandin F1α is measured in patients with chronic pulmonary heart disease, where its level was significantly lowered compared with normal controls.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID001317937
Created by
admin on Sat Dec 16 08:09:43 GMT 2023 , Edited by admin on Sat Dec 16 08:09:43 GMT 2023
|
PRIMARY | |||
|
1237611
Created by
admin on Sat Dec 16 08:09:43 GMT 2023 , Edited by admin on Sat Dec 16 08:09:43 GMT 2023
|
PRIMARY | |||
|
8URB805JJJ
Created by
admin on Sat Dec 16 08:09:43 GMT 2023 , Edited by admin on Sat Dec 16 08:09:43 GMT 2023
|
PRIMARY | |||
|
58962-34-8
Created by
admin on Sat Dec 16 08:09:43 GMT 2023 , Edited by admin on Sat Dec 16 08:09:43 GMT 2023
|
PRIMARY | |||
|
28158
Created by
admin on Sat Dec 16 08:09:43 GMT 2023 , Edited by admin on Sat Dec 16 08:09:43 GMT 2023
|
PRIMARY | |||
|
5280888
Created by
admin on Sat Dec 16 08:09:43 GMT 2023 , Edited by admin on Sat Dec 16 08:09:43 GMT 2023
|
PRIMARY |
PARENT (METABOLITE LESS ACTIVE)
SUBSTANCE RECORD